[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omron Corp Ord (OMRNF)

Omron Corp Ord (OMRNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026

Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026

OMRNF : 37.5000 (+4.46%)
OMRNY : 40.4500 (+5.50%)
OMRON Healthcare and Tricog Health strengthen collaboration in India with Tricog CardioCheck (TCC)

OMRON Healthcare and Tricog Health strengthen collaboration in India with Tricog CardioCheck (TCC)

OMRNF : 37.5000 (+4.46%)
OMRNY : 40.4500 (+5.50%)
OMRON Healthcare and UCSF launch AFib trial

OMRON Healthcare and UCSF launch AFib trial

OMRNF : 37.5000 (+4.46%)
OMRNY : 40.4500 (+5.50%)
OMRON Healthcare releases new Women's Heart Health Factbook

OMRON Healthcare releases new Women's Heart Health Factbook

OMRNF : 37.5000 (+4.46%)
OMRNY : 40.4500 (+5.50%)
OMRON (OMRNF) Receives a Buy from Goldman Sachs

Goldman Sachs analyst Yuichiro Isayama maintained a Buy rating on OMRON today and set a price target of Yen4,900.00. The company’s shares closed last Friday at $26.60.Elevate Your Investing Strategy:...

OMRNF : 37.5000 (+4.46%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.